Cancer Research Peptides

Peptides under investigation for anti-cancer properties, spanning senolytic agents, anti-angiogenic factors, immune checkpoint modulators, and telomerase-targeting compounds.

<Callout type="info"> These peptides are in various stages of research. None should be considered cancer treatments. This information is for research reference only. </Callout>

Senolytic & Anti-Aging

• FOXO4-DRI
• p16 Inhibitor Peptides
• p16/INK4a (CDKN2A)
• p21/WAF1/CIP1

Anti-Angiogenic

• Endostatin
• Angiostatin
• Tumstatin

Immune Checkpoint & Immunotherapy

• PD-1 Pathway Peptide Inhibitors
• CTLA-4 Peptide Antagonists
• GV1001
• GV1001 (Cancer Focus)
• EP-100

Telomerase & Telomere

• Epithalon
• Telomerase Peptides
• TERT Activating Peptide
• POT1 Peptide

Autophagy & Apoptosis

• TAT-Beclin-1 Conjugate
• Beclin-1-Derived Peptides
• p300 HAT Inhibitor Peptides

Antimicrobial Peptides with Anti-Cancer Properties

• LL-37
• Cathelicidin/LL-37 in Cancer
• Magainin

See Also

• Longevity & Anti-Aging
• Immune System